| THMO Snapshot | |
|---|---|
| ThermoGenesis Holdings, Inc. develops, markets and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. The company is headquartered in Rancho Cordova, California. | |
| VALUATION DATA | |
| Market Capitalization | $5,169,300 | Price to Sales | 0.00 |
| Earnings per Share | $-7.5900 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $0.6500 |
| 52 Week High | $0.265 |
| 52 Week Low | $0.56 |
| 50-Day Moving Average | $0.71 |
| 200-Day Moving Average | $-1.357 |
| All data are from Alpha Vantage as of today. For more infomation on THMO see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search